- Page 1 and 2:
Exploring patient participation in
- Page 3 and 4:
ABSTRACT Patients’ rights have be
- Page 5 and 6:
iv Patient information: the link be
- Page 7 and 8:
vi LIST OF TABLES, FIGURES AND BOXE
- Page 9 and 10:
ACKNOWLEDGEMENTS The editors would
- Page 11 and 12:
LIST OF ABBREVIATIONS ABHR alcohol-
- Page 13 and 14:
FOREWORD Health is a social value a
- Page 15 and 16:
ChApTER 1. pATIENTS’ RIGhTS AND p
- Page 17 and 18:
Box 1 .1 . contd Reporting and Lear
- Page 19 and 20:
The causal mechanisms through which
- Page 21 and 22:
» be involved in routine monitorin
- Page 23 and 24:
elationships within the complex env
- Page 25 and 26:
ChApTER 2. pATIENTS’ RIGhTS AND p
- Page 27 and 28:
CoE Recommendation 2006/7 of the Co
- Page 29 and 30:
The 2005 United States act on patie
- Page 31 and 32:
The right to participate in policy-
- Page 33 and 34:
The right to participate in quality
- Page 35 and 36:
» engaging with patient representa
- Page 37 and 38:
hampered by the written and spoken
- Page 39 and 40: prevents misunderstandings and shap
- Page 41 and 42: Health care providers should nevert
- Page 43 and 44: Recommendation 7 - Encourage the av
- Page 45 and 46: 20. Constitution of the World Healt
- Page 47 and 48: ChApTER 3. pATIENT pARTICIpATION IN
- Page 49 and 50: awareness of the sociomedical burde
- Page 51 and 52: Patient participation in hand hygie
- Page 53 and 54: Patient participation in hand hygie
- Page 55 and 56: Patient participation in hand hygie
- Page 57 and 58: Patient participation in hand hygie
- Page 59 and 60: Patient participation in hand hygie
- Page 61 and 62: Blood transfusion safety in France:
- Page 63 and 64: Blood transfusion safety in France:
- Page 65 and 66: Box 4 .1 . Definitions of adverse e
- Page 67 and 68: Fig . 4 .4 . Distribution of advers
- Page 69 and 70: Blood transfusion safety in France:
- Page 71 and 72: Blood transfusion safety in France:
- Page 73 and 74: The heterogeneity of situations and
- Page 75 and 76: Blood transfusion safety in France:
- Page 77 and 78: Blood transfusion safety in France:
- Page 79 and 80: Blood transfusion safety in France:
- Page 81 and 82: Blood transfusion safety in France:
- Page 83 and 84: Fig . 4 .12 . Patients’ response
- Page 85 and 86: Blood transfusion safety in France:
- Page 87 and 88: Blood transfusion safety in France:
- Page 89: Blood transfusion safety in France:
- Page 93 and 94: Patient safety, rights and medicati
- Page 95 and 96: Patient safety, rights and medicati
- Page 97 and 98: Fig . 5 .3 . Frequency with which d
- Page 99 and 100: Patient safety, rights and medicati
- Page 101 and 102: Patient safety, rights and medicati
- Page 103 and 104: Patient safety, rights and medicati
- Page 105 and 106: Patient safety, rights and medicati
- Page 107 and 108: ChApTER 6. pATIENT pARTICIpATION IN
- Page 109 and 110: Patient participation in elective s
- Page 111 and 112: e desirable to have a special statu
- Page 113 and 114: Patient participation in elective s
- Page 115 and 116: Patient participation in elective s
- Page 117 and 118: inspections of surgical services to
- Page 119 and 120: Patient participation in elective s
- Page 121 and 122: Patient participation in elective s
- Page 123 and 124: Patient participation in elective s
- Page 125 and 126: Patient participation in elective s
- Page 127 and 128: Patient participation in elective s
- Page 129 and 130: Patient participation in elective s
- Page 131 and 132: Patient participation in elective s
- Page 133 and 134: » being involved in monitoring and
- Page 135 and 136: Other studies on patient attitudes
- Page 137 and 138: Information about patients’ exper
- Page 139 and 140: available evidence suggests that in
- Page 141 and 142:
Adverse events Respondents from the
- Page 143 and 144:
Feeling safe Five per cent of hospi
- Page 145 and 146:
probability proportional to populat
- Page 147 and 148:
care professionals’ and patients
- Page 149 and 150:
group recommends that patient invol
- Page 151 and 152:
13. Hibbard JH et al. Can patients
- Page 153 and 154:
52. Triemstra M et al. Measuring cl
- Page 155 and 156:
2009 (http://www.bradfordresearch.n
- Page 157 and 158:
of a small-scale patient survey add
- Page 159 and 160:
Box 8 .2 . Curricula and CME Chapte
- Page 161 and 162:
is provided through interaction of
- Page 163 and 164:
Box 8 .4 . Patient education Chapte
- Page 165 and 166:
ANNEX 1. QUOTATIONS FROM INTERNATIO
- Page 167 and 168:
(2) When designing adverse event re
- Page 169 and 170:
17) If yes, do you think this was m
- Page 171 and 172:
Box A3 .1 . Reporting procedure Pat
- Page 173 and 174:
Box A3 .2 . contd Haemosiderosis Ha
- Page 175 and 176:
ANNEX 4. pATIENT QUESTIONNAIRE ABOU
- Page 177 and 178:
ANNEX 6. WhO pATIENT SAFETY pROGRAM
- Page 179 and 180:
especially those in intensive care.
- Page 181 and 182:
ANNEX 7. hANDOVER pROjECT Paul Bara
- Page 183 and 184:
(a) Provide new insight into the ro
- Page 185 and 186:
Johnson J, Barach P. Handovers of p
- Page 187 and 188:
Enhancing the patients’ role in p
- Page 189 and 190:
Enhancing the patients’ role in p